Why Is Everyone Talking About Guardant Health Stock?
When a company develops products that should be game changers in the way cancer is treated, it's going to generate a lot of buzz. That's exactly what has happened for Guardant Health (NASDAQ: GH).
Helmy Eltoukhy and AmirAli Talasaz founded Guardant Health in 2013 after both men served in various research positions at genomic sequencing pioneer Illumina. They set out to "conquer cancer" by tapping into the molecular information in tumor cells throughout all stages of cancer. And they've been successful so far.
Image source: Getty Images.
Source Fool.com
